Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer
Public ClinicalTrials.gov record NCT00958971. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Open Label Phase II Trial of TKI258 in FGFR1 Amplified and Non-amplified Metastatic or Advanced HER2 Negative Breast Cancer
Study identification
- NCT ID
- NCT00958971
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 43 participants
Conditions and interventions
Conditions
Interventions
- TKI258 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2009
- Primary completion
- Feb 28, 2011
- Completion
- Feb 28, 2011
- Last update posted
- Dec 18, 2020
2009 – 2011
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Comprehensive Blood and Cancer Center Dept CBCC (3) | Bakersfield | California | 93309 | — |
| Tower Cancer Research | Beverly Hills | California | 90211 | — |
| UCLA/ University of California Los Angeles Div. of Hematology/Oncology | Los Angeles | California | 90095 | — |
| Cancer Care Associates Medical Group Dept. of CCA | Redondo Beach | California | 90277 | — |
| Central Coast Medical Oncology Corporation | Santa Maria | California | 93454 | — |
| Florida Cancer Specialists Dept.of FloridaCancerSpec. (2) | Fort Myers | Florida | 33901 | — |
| Kansas City Cancer Center KCCC (3) | Overland Park | Kansas | 66210 | — |
| Associates in Oncology/Hematology, P.C. | Rockville | Maryland | 20850 | — |
| Comprehensive Cancer Centers of Nevada | Henderson | Nevada | 89052 | — |
| UNC/ Lineberger Comprehensive Cancer Center Dept. of Linberger Cancer Ctr | Chapel Hill | North Carolina | 27599-7295 | — |
| Northwest Cancer Specialists Northwest Office (2) | Portland | Oregon | 97210 | — |
| Texas Oncology, P.A. Dept. of Texas Oncology | Bedford | Texas | 76022 | — |
| Texas Oncology, P.A. Austin | Dallas | Texas | 75246 | — |
| Texas Oncology, P.A. Presbyterian Hospital | Dallas | Texas | 75246 | — |
| Texas Oncology, P.A. Texas Oncology - Sammons | Dallas | Texas | 75246 | — |
| Tyler Cancer Center Dept.ofTylerCancerCtr. (2) | Tyler | Texas | 75702 | — |
| Fairfax Northern Virginia Hematology Oncology Fairfax NVH | Fairfax | Virginia | 22031 | — |
| Blue Ridge Research Center at Roanoke Neurological Center Blue Ridge Cancer Care | Roanoke | Virginia | 24014 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00958971, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2020 · Synced May 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00958971 live on ClinicalTrials.gov.